Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Creasey

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|May 1, 1983
Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetaseA A Creasey, D A Eppstein, Y V Marsh, et al.
The Journal of Infectious Diseases|March 14, 1998
Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitisA J Camerota, A A Creasey, V Patla, et al.
Journal of Interferon Research|April 1, 1987
Potency stability of recombinant (Serine-17) human interferon-betaJ Geigert, D L Ziegler, B M Panschar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Site-specific mutagenesis of the human fibroblast interferon geneD F Mark, S D Lu, A A Creasey, et al.
Intensive Care Medicine|August 21, 2001
Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shockR Matyal, Y Vin, R L Delude, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Cytostatic and cytolytic effects of human recombinant tumor necrosis factor on human renal cell carcinoma cell lines derived from a single surgical specimenR Heicappell, S Naito, Y Ichinose, et al.
Cancer Research|January 1, 1987
Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell linesA A Creasey, L V Doyle, M T Reynolds, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 1999
Effects of immune complex formation and complement activation on circulating platelets in the primateD J Birmingham, L A Hebert, X P Shen, et al.
The Journal of Clinical Investigation|June 1, 1993
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shockA A Creasey, A C Chang, L Feigen, et al.
In Vitro|May 1, 1979
Biological properties of human melanoma cells in cultureA A Creasey, H S Smith, A J Hackett, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|May 1, 1983
Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetaseA A Creasey, D A Eppstein, Y V Marsh, et al.
The Journal of Infectious Diseases|March 14, 1998
Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitisA J Camerota, A A Creasey, V Patla, et al.
Journal of Interferon Research|April 1, 1987
Potency stability of recombinant (Serine-17) human interferon-betaJ Geigert, D L Ziegler, B M Panschar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Site-specific mutagenesis of the human fibroblast interferon geneD F Mark, S D Lu, A A Creasey, et al.
Intensive Care Medicine|August 21, 2001
Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shockR Matyal, Y Vin, R L Delude, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Cytostatic and cytolytic effects of human recombinant tumor necrosis factor on human renal cell carcinoma cell lines derived from a single surgical specimenR Heicappell, S Naito, Y Ichinose, et al.
Cancer Research|January 1, 1987
Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell linesA A Creasey, L V Doyle, M T Reynolds, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 1999
Effects of immune complex formation and complement activation on circulating platelets in the primateD J Birmingham, L A Hebert, X P Shen, et al.
The Journal of Clinical Investigation|June 1, 1993
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shockA A Creasey, A C Chang, L Feigen, et al.
In Vitro|May 1, 1979
Biological properties of human melanoma cells in cultureA A Creasey, H S Smith, A J Hackett, et al.
Pageof 4